you are in demo mode.    to view your own genetic profile, order your scan now.

Site search

  • your results
  • background
  • risk and prevention
  • scientific details
  • research
  • discussion
  • >>

Recent changes:
Nov 24 2009, 02:40 PM Added one risk variant for new customers of European descent
Nov 24 2009, 02:40 PM The publication for lifetime risk has been changed. Values used for the risk model have been modified accordingly

Heart Attack

Coronary heart disease involves blockages in one or more of the coronary arteries that supply blood to the heart. Heart attack occurs when these blockages cut off the blood supply to the heart causing damage to the heart muscle.

Please select a gender or population for your results.

This disease has different risk results depending on population or gender. Below you can select the ones you belong to.

Ethnicity: 

Gender:   

Disease subtype:

Results can vary according to population and/or gender. Results currently based on:

European ancestry

Trait_world_map

change

Male

Trait_male_female

change

sub-type:   MI  change



Mi
According to the selected literature, the relative genetic risk calculated from your genotype for males of European ancestry is 0.95. This corresponds to a 39.8% lifetime risk of developing heart attack, which is 5% less than for males of European ancestry in general (source) . Note that these calculations may not include all risk factors.
The lifetime risk of your type
It is estimated that 40 of every 100 males of European ancestry with your genotype variants develop this disease in their lifetime.
Mi
The average lifetime risk
On average, about 42 of every 100 males of European ancestry develop this disease in their lifetime.
Mi

Consult with our experts

Need something clarified? If so, please feel free to contact our experts. Based on the nature of your questions, we may refer you to a genetic counselor.

ask a question about Heart Attack

Keep in mind

These are the results of calculations comparing your genetic sequence to sequence of participants in studies published in the world literature on genetic risk for this disease. Read more about how deCODEme calculates risks.

This test was developed and its performance characteristics determined by the deCODE genetics Diagnostic Laboratory. It has not been cleared or approved by the U. S. Food and Drug Administration (FDA).